L Beaugerie, M Svrcek, P Seksik, AM Bouvier, T Simon… - Gastroenterology, 2013 - infona.pl
There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated with immunosuppressants …
L Beaugerie, M Svrcek, P Seksik, AM Bouvier… - …, 2013 - europepmc.org
Methods We followed and collected data from 19,486 patients with IBD (60.3% with Crohn's disease, 30.1% receiving thiopurine therapy) enrolled in CESAME from May 2004 and June …
L Beaugerie, M Svrcek, P Seksik, AM Bouvier… - Gastroenterology, 2013 - cir.nii.ac.jp
Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease | CiNii Research CiNii 国立情報学研究所 学術 …
L Beaugerie, M Svrcek, P Seksik… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Background & aims There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated with …
L Beaugerie, M Svrcek, P Seksik, AM Bouvier… - …, 2013 - hal.science
BACKGROUND AND AIMS:: There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated …
L Beaugerie, M Svrcek, P Seksik… - …, 2013 - hal.sorbonne-universite.fr
BACKGROUND AND AIMS:: There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated …
L Beaugerie, M Svrcek, P Seksik, AM Bouvier… - …, 2013 - gastrojournal.org
Background & Aims There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated with …
L Beaugerie, M Svrcek, P Seksik… - …, 2013 - hal.sorbonne-universite.fr
BACKGROUND AND AIMS:: There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated …